RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
Pham LT, Peng H, Ueno M, Kohno S, Kasada A, Hosomichi K, Sato T, Kurayoshi K, Kobayashi M, Tadokoro Y, Kasahara A, Shoulkamy MI, Xiao B, Worley PF, Takahashi C, Tajima A, Hirao A.
Pham LT, et al. Among authors: worley pf.
Biochem Biophys Res Commun. 2022 Sep 17;621:74-79. doi: 10.1016/j.bbrc.2022.06.089. Epub 2022 Jun 30.
Biochem Biophys Res Commun. 2022.
PMID: 35810594